Telemedicine for sarcoma patient care

Abstract

Telemedicine is being incorporated into routine healthcare, including oncology. The integration of telemedicine with patient electronic medical records and the adoption of virtual provider-patient encounters was accelerated by the SARS-CoV2 worldwide pandemic. Although telemedicine has existed for more than 50 years, the impact of telemedicine on patient care and health outcomes is relatively understudied, and little research has been conducted on telehealth in the care of patients with sarcoma. This review discusses the potential applications of telemedicine to the care of patients with sarcoma and some of the data available on patient and provider preferences for telemedicine vs. in-person healthcare encounters. Some of the areas of care in which greater adoption of telemedicine may be beneficial to patients with sarcoma are also discussed.

Keywords

Sarcoma / telemedicine / telepathology / telehealth / virtual / multidisciplinary

References

[1] Zundel KM.Telemedicine: history, applications, and impact on librarianship.Bull Med Libr Assoc1996;84:71-9 PMCID:PMC226126

[2] Freiburger G,Piper D.The STARPAHC collection: part of an archive of the history of telemedicine.J Telemed Telecare2007;13:221-3

[3] Doolittle GC.Practising oncology via telemedicine.J Telemed Telecare1997;3:63-70

[4] Raut CP,Hornick JL.High rates of histopathologic discordance in sarcoma with implications for clinical care.JCO2011;29:10065

[5] Rupani A,Jones RL,Thway K.Diagnostic differences in expert second-opinion consultation cases at a tertiary sarcoma center.Sarcoma2020;2020:9810170 PMCID:PMC7542501

[6] Tucker JH,Spatz A,Brugal G.An experimental inter-expert telepathology network using static imaging.J Clin Pathol2001;54:752-7 PMCID:PMC1731288

[7] Voelker HU,Strehl A,Stuefe A.Telepathological evaluation of paediatric histological specimens in support of a hospital in Tanzania.Afr Health Sci2020;20:1313-21 PMCID:PMC7751540

[8] Wamala D,Dworak O.Feasibility and diagnostic accuracy of Internet-based dynamic telepathology between Uganda and Germany.J Telemed Telecare2011;17:222-5

[9] Racanelli D,Baldazzi D.Next-generation sequencing approaches for the identification of pathognomonic fusion transcripts in sarcomas: the experience of the Italian ACC sarcoma working group.Front Oncol2020;10:489

[10] Italiano A,Soubeyran I,Esperou H.Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.BMC Cancer2021;21:1180 PMCID:PMC8570026

[11] Blay JY,Penel N.Improved survival using specialized multidisciplinary board in sarcoma patients.Ann Oncol2017;28:2852-9 PMCID:PMC5834019

[12] von Mehren M,Bui MM.NCCN guidelines insights: soft tissue sarcoma, version 1.2021.J Natl Compr Canc Netw2020;18:1604-12

[13] Siegel GW,Chugh R.The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework.J Multidiscip Healthc2015;8:109-15 PMCID:PMC4340372

[14] Rajasekaran RB,Cosker TDA,Carr A.Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic?.BMC Musculoskelet Disord2021;22:18 PMCID:PMC7784619

[15] Bate J,Donkin A,Whelan J.Patient perspectives on a national multidisciplinary team meeting for a rare cancer.Eur J Cancer Care2019;28:e12971

[16] WHO classification of tumours editorial board. Soft tissue and bone tumours. International Agency for Research on Cancer: Lyon, France. 2020. Available from: https://publications.Iarc.fr/588 [Last accessed on 27 Sep 2022].

[17] Smrke A,Wilson R.Telemedicine during the COVID-19 pandemic: impact on care for rare cancers.JCO Glob Oncol2020;6:1046-51 PMCID:PMC7392777

[18] McCabe HM,Cowie F.What matters to US: impact of telemedicine during the pandemic in the care of patients with sarcoma across scotland.JCO Glob Oncol2021;7:1067-73 PMCID:PMC8457876

[19] Parker PA,de Moor C,Kudelka AP.Breaking bad news about cancer: patients’ preferences for communication.J Clin Oncol2001;19:2049-56

[20] Harris J,Armes J.The emerging role of digital health in monitoring and supporting people living with cancer and the consequences of its treatments.Curr Opin Support Palliat Care2018;12:268-75

[21] Denis F,Septans AL.Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer.JAMA2019;321:306-7 PMCID:PMC6439676

[22] Maguire R,Kotronoulas G.Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).BMJ2021;374:n1647 PMCID:PMC8293749

[23] Mooney KH,Wong B.Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT.Cancer Med2017;6:537-46 PMCID:PMC5345623

[24] Galizia D,Geuna E.Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: a prospective study.Cancer Med2018;7:4339-44 PMCID:PMC6144000

[25] Youn P,Constine LS.Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: a population-based study of 28,844 patients.Cancer2014;120:2334-42

[26] Baker LH,Reinke DK,Zebrack BJ.Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study.J Cancer Metastasis Treat2020;6:24 PMCID:PMC8513741

[27] Tonning Olsson I,Wang M.Neurocognitive and psychosocial outcomes in adult survivors of childhood soft-tissue sarcoma: a report from the St. Jude Lifetime Cohort.Cancer2020;126:1576-84 PMCID:PMC7104616

[28] Drabbe C,De Rooij BH.The age-related impact of surviving sarcoma on health-related quality of life: data from the SURVSARC study.ESMO Open2021;6:100047 PMCID:PMC7844567

[29] Roberts AL,Smith L,Potts HWW.Digital health behaviour change interventions targeting physical activity and diet in cancer survivors: a systematic review and meta-analysis.J Cancer Surviv2017;11:704-19 PMCID:PMC5671545

[30] Cox A,Marcu A.Cancer survivors’ experience with telehealth: a systematic review and thematic synthesis.J Med Internet Res2017;19:e11 PMCID:PMC5259589